Previous close | 3.2000 |
Open | 3.2300 |
Bid | 2.9700 x 1200 |
Ask | 3.5000 x 1000 |
Day's range | 3.1800 - 3.3100 |
52-week range | 2.0000 - 16.3800 |
Volume | |
Avg. volume | 128,842 |
Market cap | 124.879M |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed U.S. Provisional Patent Application 63461609 on April 25, 2023 covering the mechanical structure, operation, and controlling aspects of a treatment device monitored by sensors and capable of stimulating the male sexual organs based on user preferences ASHKELON, Israel and VANCOUVER, British Columbia, April 27, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Com
BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. received a positive opinion from the examiner of the PCT for its method that enables its AI-based device to identify a level of satisfaction according to parameters received from the device sensorsASHKELON, Israel and VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today it has received a positive opinion fro
Plans to formulate proprietary CBD oil and brand through a licensed grower in Israel for distribution outside of Israel in its AI based device and EZ-G deviceVANCOUVER, British Columbia and ASHKELON, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced plans to formulate a proprietary CBD oil and brand through a licensed grower in Israel for distribution outside of Israel for its new artificial i
BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed US Provisional Patent Application 63/450,503 on March 7, 2023 covering the mechanical structure, operation, and controlling aspects of an additional smart female treatment deviceASHKELON, Israel and VANCOUVER, British Columbia, March 08, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today plans to enter the multibillion-dollar Sextech Indu
The new full scale PCT application for the EZ-G device, comprised of a structure and one or more moving and vibrating elements, will utilize Artificial Intelligence (AI) to send data about learned sexual preferences to the cloud to heighten arousal, and intimacyASHKELON, Israel and VANCOUVER, British Columbia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today that in addition to the US Provisional Pate
ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (C.S.E.: BYND) ("BYND Cannasoft" or the "Company") today issued a letter to shareholders from its Chief Executive Officer and Director, Yftah Ben Yaackov. Successful Nasdaq Uplisting On May 31, 2022, BYND Cannasoft was approved for trading on the Nasdaq Capital Market. This listing represents a significant milestone for BYND Cannasoft and enhances our ability to crea
PCT patent application could potentially cover the EZ-G device as a sex toy, as well as a double-faceted condomASHKELON, Israel and VANCOUVER, British Columbia, Dec. 07, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today it is in the advanced stages of expanding its EZ-G device's applications into the leisure field of sex toys. In addition to potentially treating annoying phenomena in the female reproductive sys
ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 01, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today the filing of a patent application for its EZ-G device to include an innovative double-faceted condom design. The double-faceted condom is designed to help treat various problems related to intimate relationships while making the sexual experience much more pleasurable for everyone involved. BYND Cannaso
A patent pending Double-faceted condom to enhance sexual pleasure marks BYND Cannasoft’s entry in a multi-billion-dollar marketASHKELON, Israel and VANCOUVER, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today it is aiming to enter into the global condom market, which is expected to grow to USD $10.97 billion by 2030. The company intends to offer consumers a revolutionary design for se
The agreement marks BYND Cannasoft’s commitment to penetrating additional markets and deepening services in consumer goods companies with its legacy CRM platformASHKELON, Israel and VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today that it has signed an agreement for the provision of software services with one of Israel’s leading air conditioning companies. Under the terms
Strengthened balance sheet, increased gross margins, and reduced expenses provide increased focus on growth based on BYND Cannasoft’s CRM SaaS platform, medical cannabis, and EZ-G deviceASHKELON, Israel and VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today future plans for growth after posting a 494% increase in assets for the nine-month period ended September 30, 2022. The
Company reports 494% growth in 2022 assets to $33 million USD and strengthened balance sheet while increasing gross margins and reducing lossesVANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) (“BYND” or the “Company”), has released its financial results for the nine-month period ended September 30, 2022. Full versions of BYND’s unaudited consolidated interim financial statements and management discussion and analysis for the
International Searching Authority under the Patent Cooperation Treaty (“PCT”) provides non-binding opinion that one of the inventions comprising the EZ-G device is novel and inventiveASHKELON, Israel and VANCOUVER, British Columbia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today that as part of the PCT patent application process for the EZ-G device, an International Searching Authority (“ISA”) exami
VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 27, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today its Israeli subsidiary signed an agreement with Globus Pharma LTD, a subsidiary of Israeli-based Together Pharma Ltd (TA: TGTR), for the cultivation, production, and distribution of medical cannabis products that are expected to generate significant revenues for the company before costs of manufacturing
A new interview with Yftah Ben Yaackov, CEO and Director of BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) BYND Cannasoft Enterprises CEO Discusses Marijuana Reform and Corporate Advancements in Audio Interview with SmallCapVoice.com AUSTIN, Texas, Oct. 25, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Yftah Ben Yaackov, CEO of BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND” or the “Company”), to discuss
VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 24, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today that it entered into a consulting service with Matrix Medika, a developer of medical systems specialized in assisting companies in obtaining regulatory approval for medical devices under development. The service will be given as part of the agreement with Arkit Studio, a company that provides the service
Approval by the Medical Cannabis Unit at the Ministry of Health of the State of Israel was provided as part of the process of obtaining a full license to engage in medical cannabis without direct contact with the substance that will allow trading in medical cannabis products through an agreement with a licensed cannabis grower in Israel.The medical cannabis products market in Israel has approximately 150,000 users with an annual sales volume of about US$0.5 billion; BYND Cannasoft intends to cap
VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) is pleased to announce that it has agreed to raise up to CAD$649,500 from certain investors by way of a non-brokered private placement. Specifically, the Company has agreed to issue up to 150,000 common shares at an issue price of $4.33 per share (the “Private Placement”). The Private Placement is scheduled to close prior to the end of October and i
Beta version of software provided as SAAS includes BYND Cannasoft's proprietary C.R.M. System - Job Management (BENEFIT), as well as a module system for managing farms and greenhouses with varied crops (CANNASOFT)VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) announced that its subsidiary BYND - Beyond Solutions Ltd. has signed an agreement with the Weizmann Institute of Science for the use of i
VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) announced today that, further to its news release of September 19, 2022, it has completed the purchase of all of the issued and outstanding shares of Zigi Carmel Initiatives & Investments Ltd. (“ZC”) from Carmel Zigdon. Under the terms of the share purchase agreement, the Company issued 7,920,000 common shares to the vendor. These shares are subject
AUSTIN, Texas, Sept. 20, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Yftah Ben Yaackov, CEO of BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (CNSX:BYND.CN) (“BYND” or the “Company”), to discuss the Company’s operations, innovations and outlook for the coming year. The full interview can be heard at: https://www.smallcapvoice.com/2022-interview-bynd-cannasoft-bcan/. BYND is an Israel-based integrated software/cannabis com
ZC owns the patent pending intellectual property for a CBD-based therapeutic device combined with software designed to treat phenomena related to women's health issues by regulating the flow of low-concentration CBD oils into the soft tissues of the female reproductive systemVANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) announced today that it has signed a share purchase agreement to acquire 10
ZC owns the patent pending intellectual property for a CBD-based therapeutic device combined with software designed to treat phenomena related to women's health issues by regulating the flow of low-concentration CBD oils into the soft tissues of the female reproductive systemVANCOUVER, British Columbia, Sept. 18, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or the “Company”) announced today that it has signed a share purchase agreement to acquire 10